http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Resveratrol inhibits growth of experimental abdominal aortic aneurysm associated with upregulation of angiotensin-converting enzyme 2 http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13242 Wed 07 Apr 2021 14:01:24 AEST ]]> A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:12224 Wed 07 Apr 2021 14:00:31 AEST ]]> Wnt signaling pathway inhibitor Sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11954 Wed 07 Apr 2021 13:57:14 AEST ]]> Renal denervation promotes atherosclerosis in hypertensive apolipoprotein E-Deficient mice infused with angiotensin II http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11502 Wed 07 Apr 2021 13:56:48 AEST ]]> Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11278 Wed 07 Apr 2021 13:56:37 AEST ]]> Mouse models for abdominal aortic aneurysm http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:16915 Thu 01 Dec 2022 13:43:10 AEDT ]]> Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15657 Mon 24 Jan 2022 14:15:13 AEDT ]]>